EcoDrugPlus

Adrenoceptor Alpha 2a

Ensembl ID : ENSMMDG00005010413
Gene Symbol: ADRA2A
1 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSMMDG00005003672
Gene Symbol: ADRA2B
1 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSMMDG00005009275
Gene Symbol: ADRA2B
1 Cross references
149 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSMMDG00005000087
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSMMDG00005023484
Gene Symbol: ADRA2C
1 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSMMDG00005019794
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSMMDG00005022646
Gene Symbol: ADRB2A
1 Cross references
195 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSMMDG00005024803
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1-Like

Ensembl ID : ENSMMDG00005010316
Gene Symbol: LOC115354901
3 Cross references
346 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1-Like

Ensembl ID : ENSMMDG00005010318
Gene Symbol: LOC115355242
3 Cross references
343 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSMMDG00005016550
Gene Symbol: GAA
1 Cross references
234 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSMMDG00005015522
Gene Symbol: LOC115369555
2 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).